Regulation of MDM2 Promoters in Gliomas
Author Information
Author(s): Dimitriadi M, Poulogiannis G, Liu L, Bäcklund L M, Pearson D M, Ichimura K, Collins V P
Primary Institution: University of Cambridge
Hypothesis
The study investigates the expression of P1- and P2-MDM2 promoters in gliomas and their regulation by p53.
Conclusion
The P2 promoter can be activated independently of p53 in astrocytic gliomas, and MDM2 amplification primarily drives expression from the P1 promoter.
Supporting Evidence
- MDM2 is amplified in about 10% of glioblastomas.
- Transcription from the P2 promoter can occur in the absence of p53.
- Elevated MDM2 mRNA levels are driven by the P1 promoter in MDM2-amplified tumors.
- SNP309 showed a borderline association with survival in glioblastoma patients.
Takeaway
This study found that glioma cells can produce MDM2 even without the p53 protein, and that one part of the MDM2 gene is more active when the gene is amplified.
Methodology
RT-PCR was used to study P1- and P2-MDM2 transcript expression in various glioma samples and cell lines.
Potential Biases
Potential biases may arise from the selection of tumor samples and the methods used for gene status determination.
Limitations
The study's sample size may limit the generalizability of the findings.
Participant Demographics
The study included 73 glioma patients, with a mix of glioblastomas, anaplastic astrocytomas, and astrocytomas.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website